{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Script to\n",
    "1. get dosage range overlap across datasets, dosage range in GDSC andother metdata for each drug for analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "__author__ = 'Aanchal'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import FUNCTIONS as f\n",
    "import matplotlib.pyplot as plt\n",
    "import numpy as np\n",
    "\n",
    "import warnings\n",
    "warnings.filterwarnings('ignore')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "impClsOnly=1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "plotting_df=pd.DataFrame();"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### fetch dosage overlap"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "dr_metadata= f.get_common_drugs_metadata(\"../data/metadata_2019_08_15_aanchal.xlsx\", \"common_drugs\")\n",
    "\n",
    "plotting_df['Standard drug name']=dr_metadata['Standard drug name']\n",
    "plotting_df['dosage range overlap']=dr_metadata['dosage range overlap']\n",
    "plotting_df['GDSC dosage length']=dr_metadata['GDSC dosage length']\n",
    "plotting_df['GDSC min dosage']=dr_metadata['GDSC min dosage']\n",
    "plotting_df['GDSC max dosage']=dr_metadata['GDSC max dosage']"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## INITIALIZATION "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "FeatureMatrix=pd.read_csv('../data_processed/FittedCurvesCommonPairs_features/Feature_Matrix_FLatPerDrugFitting_15features.csv') # #Normalized_outliersCapped\n",
    "\n",
    "FeatureMatrix=FeatureMatrix[['Standard cell line name','Standard drug name','IS','mae_fitness','ic50_mode','m_mode','log2(max_dosage_bothDatasets)']]\n",
    "\n",
    "pair_dosages=pd.read_csv('../data_processed/GDSC_pair_dosage_range.csv').sort_values('Standard cell line name')\n",
    "FeatureMatrix=pd.merge(FeatureMatrix, pair_dosages,on=['Standard cell line name','Standard drug name']) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "mu, sigma, Amp for 2 modes=> [  3.11407597   2.40712364 200.193668    10.19748103   1.65014358\n",
      " 135.71820865]\n",
      "Th=mu+std of 1st gaussian pofile: 7.063382706349541\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "from pylab import hist\n",
    "'''hist(FeatureMatrix['ic50_mode'] , bins=100) #FeatureMatrix['IS'] #FeatureMatrix['m_mode']\n",
    "plt.title('Distribution of ic50_mode for all pairs')\n",
    "plt.xlabel('value of ic50_mode')\n",
    "plt.ylabel('# pairs')\n",
    "plt.show()'''\n",
    "#temp=df[df['sensitivity_calls_ic50_label']==1]\n",
    "#hist(temp['ic50_mode'] , bins=100)\n",
    "\n",
    "[mus,stds, params,xh,yh] = f.fit_mixtureOfGaussians(FeatureMatrix[['ic50_mode']],[2.5,5,130,  10,5,60])\n",
    "\n",
    "#st_ind=np.where(params==max(mus))\n",
    "th=mus[0]+2*stds[0] #not using anymore since both the dsitributions mus tbe used to separate the 2 modes..not just 1\n",
    "\n",
    "th= f.split_bimodal(xh, f.bimodal(xh,params[0],params[1],params[2],params[3],params[4],params[5])  ,mus)[0]\n",
    "\n",
    "plt.axvline(x=mus[0], color='g', linestyle='--', label='mu1')\n",
    "plt.axvline(x=mus[1], color='g', linestyle='--', label='mu2')\n",
    "plt.axvline(x=th ,color='k', linestyle='--', label='threshold')\n",
    "plt.xlabel('IC50_mode')\n",
    "plt.ylabel('# Pairs')\n",
    "plt.title('chosen threshold to separate resistant pairs='+str( th.round(2)) )\n",
    "print(\"Th=mu+std of 1st gaussian pofile:\", th)\n",
    "plt.savefig('../figures/InconsistencyFactorAnalysis/IC50_mode_distibution.svg')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "FeatureMatrix['Sensitivity_basedOnIC50th'] = np.where(FeatureMatrix['ic50_mode']> th, 1, 0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "7.063382706349541"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "th"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "#filter Cls which havent been tested for all drugs\n",
    "if(impClsOnly==1):\n",
    "    all_cls=FeatureMatrix.groupby(FeatureMatrix['Standard cell line name']).count()[['Standard drug name']]\n",
    "    FeatureMatrix_impcls=FeatureMatrix.loc[FeatureMatrix['Standard cell line name'].isin(all_cls[all_cls['Standard drug name']==15].index)]\n",
    "else:\n",
    "    FeatureMatrix_impcls=FeatureMatrix\n",
    "\n",
    "#filter resistant Cls\n",
    "FeatureMatrix_sensitivePairs=FeatureMatrix_impcls[FeatureMatrix_impcls['ic50_mode']<=th]\n",
    "\n",
    "#get mean IS\n",
    "drug_wise_mean=FeatureMatrix_sensitivePairs.groupby('Standard drug name')['Standard drug name','IS'].mean() #takes med of all cols\n",
    "drug_wise_mean.rename(columns={'IS': 'mean IS'}, inplace=True)\n",
    "\n",
    "\n",
    "#get median IS\n",
    "drug_wise_median=FeatureMatrix_sensitivePairs.groupby('Standard drug name')['Standard drug name','IS','ic50_mode'].median() #takes med of all cols\n",
    "drug_wise_median.rename(columns={'IS': 'median IS', 'ic50_mode': 'median ic50_mode'}, inplace=True)\n",
    "\n",
    "AAA_matrix=FeatureMatrix_sensitivePairs\n",
    "AAA_matrix=AAA_matrix.set_index('Standard drug name')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "675"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(FeatureMatrix_sensitivePairs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "#df=FeatureMatrix_sensitivePairs.groupby(FeatureMatrix_sensitivePairs['Standard drug name']).agg({'Sensitivity_basedOnIC50nMaxDosage': [sum, \"count\"]})#['Standard drug name','Sensitivity'].describe()#.count()#.size()#.unstack()\n",
    "#df['fraction_resistant_CLs']=df['Sensitivity_basedOnIC50nMaxDosage']['sum']/df['Sensitivity_basedOnIC50nMaxDosage']['count']#['Sensitivity'][['sum']]#df['%age resistant CLs']=df['Standard drug name']\n",
    "#Sensitivity_basedOnIC50th shud be used to find fraction of resistant cls\n",
    "\n",
    "plotting_df['mean IS']=drug_wise_mean['mean IS']\n",
    "plotting_df['median IS']=drug_wise_median['median IS']\n",
    "plotting_df['median ic50_mode']=drug_wise_median['median ic50_mode']\n",
    "plotting_df['#total CLs']=FeatureMatrix.groupby('Standard drug name').count()['Standard cell line name']\n",
    "plotting_df['#CLs tested for all']=FeatureMatrix_impcls.groupby('Standard drug name').count()['Standard cell line name']\n",
    "plotting_df['#sensitive CLs']=FeatureMatrix_sensitivePairs.groupby('Standard drug name').count()['Standard cell line name']\n",
    "\n",
    "plotting_df['Target Pathway']=dr_metadata['Target Pathway']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [],
   "source": [
    "###plotting_df=AAA_matrix.merge(plotting_df,left_index=True, right_index=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [],
   "source": [
    "if(impClsOnly==1):\n",
    "    plotting_df.to_csv('../data_processed/InconsistencyFactorAnalysis/drug_analysis_onlySensitiveCLs_testedFor15drugs.csv')\n",
    "else:\n",
    "    plotting_df.to_csv('../data_processed/InconsistencyFactorAnalysis/drug_analysis_onlySensitiveCLs.csv') "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Standard drug name</th>\n",
       "      <th>dosage range overlap</th>\n",
       "      <th>GDSC dosage length</th>\n",
       "      <th>GDSC min dosage</th>\n",
       "      <th>GDSC max dosage</th>\n",
       "      <th>mean IS</th>\n",
       "      <th>median IS</th>\n",
       "      <th>median ic50_mode</th>\n",
       "      <th>#total CLs</th>\n",
       "      <th>#CLs tested for all</th>\n",
       "      <th>#sensitive CLs</th>\n",
       "      <th>Target Pathway</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>name</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Crizotinib</th>\n",
       "      <td>Crizotinib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.113579</td>\n",
       "      <td>0.104483</td>\n",
       "      <td>2.798528</td>\n",
       "      <td>111</td>\n",
       "      <td>66</td>\n",
       "      <td>57</td>\n",
       "      <td>RTK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Erlotinib</th>\n",
       "      <td>Erlotinib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.104502</td>\n",
       "      <td>0.093517</td>\n",
       "      <td>3.684525</td>\n",
       "      <td>97</td>\n",
       "      <td>66</td>\n",
       "      <td>34</td>\n",
       "      <td>EGFR signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Lapatinib</th>\n",
       "      <td>Lapatinib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.111668</td>\n",
       "      <td>0.102102</td>\n",
       "      <td>3.160882</td>\n",
       "      <td>104</td>\n",
       "      <td>66</td>\n",
       "      <td>44</td>\n",
       "      <td>EGFR signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NVP-TAE684</th>\n",
       "      <td>NVP-TAE684</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.158247</td>\n",
       "      <td>0.145354</td>\n",
       "      <td>1.236829</td>\n",
       "      <td>111</td>\n",
       "      <td>66</td>\n",
       "      <td>58</td>\n",
       "      <td>RTK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Nilotinib</th>\n",
       "      <td>Nilotinib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.119039</td>\n",
       "      <td>0.111031</td>\n",
       "      <td>2.913680</td>\n",
       "      <td>253</td>\n",
       "      <td>66</td>\n",
       "      <td>47</td>\n",
       "      <td>ABL signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Nutlin-3a</th>\n",
       "      <td>Nutlin-3a</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-5.000000</td>\n",
       "      <td>3.000000</td>\n",
       "      <td>0.103574</td>\n",
       "      <td>0.096268</td>\n",
       "      <td>3.630165</td>\n",
       "      <td>330</td>\n",
       "      <td>66</td>\n",
       "      <td>27</td>\n",
       "      <td>p53 pathway</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>PD0325901</th>\n",
       "      <td>PD0325901</td>\n",
       "      <td>6.643856</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-10.000000</td>\n",
       "      <td>-2.000000</td>\n",
       "      <td>0.169005</td>\n",
       "      <td>0.156612</td>\n",
       "      <td>1.715962</td>\n",
       "      <td>326</td>\n",
       "      <td>66</td>\n",
       "      <td>43</td>\n",
       "      <td>ERK MAPK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>PHA-665752</th>\n",
       "      <td>PHA-665752</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.099693</td>\n",
       "      <td>0.088355</td>\n",
       "      <td>3.426608</td>\n",
       "      <td>111</td>\n",
       "      <td>66</td>\n",
       "      <td>47</td>\n",
       "      <td>RTK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>PLX-4720</th>\n",
       "      <td>PLX-4720</td>\n",
       "      <td>7.678072</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-4.678072</td>\n",
       "      <td>3.321928</td>\n",
       "      <td>0.094246</td>\n",
       "      <td>0.085146</td>\n",
       "      <td>5.391576</td>\n",
       "      <td>322</td>\n",
       "      <td>66</td>\n",
       "      <td>17</td>\n",
       "      <td>ERK MAPK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Paclitaxel</th>\n",
       "      <td>Paclitaxel</td>\n",
       "      <td>5.356144</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-11.287712</td>\n",
       "      <td>-3.287712</td>\n",
       "      <td>0.219389</td>\n",
       "      <td>0.222481</td>\n",
       "      <td>-4.787388</td>\n",
       "      <td>107</td>\n",
       "      <td>66</td>\n",
       "      <td>66</td>\n",
       "      <td>Mitosis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Palbociclib</th>\n",
       "      <td>Palbociclib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-6.000000</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>0.163515</td>\n",
       "      <td>0.161882</td>\n",
       "      <td>3.168589</td>\n",
       "      <td>271</td>\n",
       "      <td>66</td>\n",
       "      <td>49</td>\n",
       "      <td>Cell cycle</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Saracatinib</th>\n",
       "      <td>Saracatinib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.115429</td>\n",
       "      <td>0.113814</td>\n",
       "      <td>3.276709</td>\n",
       "      <td>111</td>\n",
       "      <td>66</td>\n",
       "      <td>43</td>\n",
       "      <td>RTK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Selumetinib</th>\n",
       "      <td>Selumetinib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-6.000000</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>0.162186</td>\n",
       "      <td>0.148147</td>\n",
       "      <td>3.407303</td>\n",
       "      <td>314</td>\n",
       "      <td>66</td>\n",
       "      <td>33</td>\n",
       "      <td>ERK MAPK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Sorafenib</th>\n",
       "      <td>Sorafenib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-6.000000</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>0.122516</td>\n",
       "      <td>0.126827</td>\n",
       "      <td>2.562305</td>\n",
       "      <td>107</td>\n",
       "      <td>66</td>\n",
       "      <td>44</td>\n",
       "      <td>RTK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Tanespimycin</th>\n",
       "      <td>Tanespimycin</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-8.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.209852</td>\n",
       "      <td>0.206563</td>\n",
       "      <td>0.063913</td>\n",
       "      <td>330</td>\n",
       "      <td>66</td>\n",
       "      <td>66</td>\n",
       "      <td>Protein stability and degradation</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "             Standard drug name  dosage range overlap  GDSC dosage length  \\\n",
       "name                                                                        \n",
       "Crizotinib           Crizotinib              8.000000                 8.0   \n",
       "Erlotinib             Erlotinib              8.000000                 8.0   \n",
       "Lapatinib             Lapatinib              8.000000                 8.0   \n",
       "NVP-TAE684           NVP-TAE684              8.000000                 8.0   \n",
       "Nilotinib             Nilotinib              8.000000                 8.0   \n",
       "Nutlin-3a             Nutlin-3a              8.000000                 8.0   \n",
       "PD0325901             PD0325901              6.643856                 8.0   \n",
       "PHA-665752           PHA-665752              8.000000                 8.0   \n",
       "PLX-4720               PLX-4720              7.678072                 8.0   \n",
       "Paclitaxel           Paclitaxel              5.356144                 8.0   \n",
       "Palbociclib         Palbociclib              8.000000                 8.0   \n",
       "Saracatinib         Saracatinib              8.000000                 8.0   \n",
       "Selumetinib         Selumetinib              8.000000                 8.0   \n",
       "Sorafenib             Sorafenib              8.000000                 8.0   \n",
       "Tanespimycin       Tanespimycin              8.000000                 8.0   \n",
       "\n",
       "              GDSC min dosage  GDSC max dosage   mean IS  median IS  \\\n",
       "name                                                                  \n",
       "Crizotinib          -7.000000         1.000000  0.113579   0.104483   \n",
       "Erlotinib           -7.000000         1.000000  0.104502   0.093517   \n",
       "Lapatinib           -7.000000         1.000000  0.111668   0.102102   \n",
       "NVP-TAE684          -7.000000         1.000000  0.158247   0.145354   \n",
       "Nilotinib           -7.000000         1.000000  0.119039   0.111031   \n",
       "Nutlin-3a           -5.000000         3.000000  0.103574   0.096268   \n",
       "PD0325901          -10.000000        -2.000000  0.169005   0.156612   \n",
       "PHA-665752          -7.000000         1.000000  0.099693   0.088355   \n",
       "PLX-4720            -4.678072         3.321928  0.094246   0.085146   \n",
       "Paclitaxel         -11.287712        -3.287712  0.219389   0.222481   \n",
       "Palbociclib         -6.000000         2.000000  0.163515   0.161882   \n",
       "Saracatinib         -7.000000         1.000000  0.115429   0.113814   \n",
       "Selumetinib         -6.000000         2.000000  0.162186   0.148147   \n",
       "Sorafenib           -6.000000         2.000000  0.122516   0.126827   \n",
       "Tanespimycin        -8.000000         0.000000  0.209852   0.206563   \n",
       "\n",
       "              median ic50_mode  #total CLs  #CLs tested for all  \\\n",
       "name                                                              \n",
       "Crizotinib            2.798528         111                   66   \n",
       "Erlotinib             3.684525          97                   66   \n",
       "Lapatinib             3.160882         104                   66   \n",
       "NVP-TAE684            1.236829         111                   66   \n",
       "Nilotinib             2.913680         253                   66   \n",
       "Nutlin-3a             3.630165         330                   66   \n",
       "PD0325901             1.715962         326                   66   \n",
       "PHA-665752            3.426608         111                   66   \n",
       "PLX-4720              5.391576         322                   66   \n",
       "Paclitaxel           -4.787388         107                   66   \n",
       "Palbociclib           3.168589         271                   66   \n",
       "Saracatinib           3.276709         111                   66   \n",
       "Selumetinib           3.407303         314                   66   \n",
       "Sorafenib             2.562305         107                   66   \n",
       "Tanespimycin          0.063913         330                   66   \n",
       "\n",
       "              #sensitive CLs                     Target Pathway  \n",
       "name                                                             \n",
       "Crizotinib                57                      RTK signaling  \n",
       "Erlotinib                 34                     EGFR signaling  \n",
       "Lapatinib                 44                     EGFR signaling  \n",
       "NVP-TAE684                58                      RTK signaling  \n",
       "Nilotinib                 47                      ABL signaling  \n",
       "Nutlin-3a                 27                        p53 pathway  \n",
       "PD0325901                 43                 ERK MAPK signaling  \n",
       "PHA-665752                47                      RTK signaling  \n",
       "PLX-4720                  17                 ERK MAPK signaling  \n",
       "Paclitaxel                66                            Mitosis  \n",
       "Palbociclib               49                         Cell cycle  \n",
       "Saracatinib               43                      RTK signaling  \n",
       "Selumetinib               33                 ERK MAPK signaling  \n",
       "Sorafenib                 44                      RTK signaling  \n",
       "Tanespimycin              66  Protein stability and degradation  "
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "plotting_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
